Physical activity in natural settings offers benefits over other exercise

Neu­ro­crine Bio­sciences re­port­ed that its pill for ma­jor de­pres­sive dis­or­der re­duced scores on a de­pres­sion sever­i­ty scale at about one month in a Phase 2

First Wave Bio­Phar­ma’s merg­er plans: The Flori­da biotech said it plans to merge with Im­muno­genX, an­oth­er gas­troin­testi­nal dis­eases com­pa­ny that is de­vel­op­ing an oral can­di­date